We work in partnership with international global health organisations, foundations and their partners in developing countries
Tackling global health issues requires an in-depth understanding of the complex forces that shape health worldwide. Our global health team works in partnership with international organisations, foundations, NGOs and other public bodies to conduct healthcare research that helps address a wide range of global health challenges.
We are well-positioned to conduct research in the global health arena because of our geographic reach, our healthcare expertise and experience with various populations across the health system at both a national and community level.
We have conducted healthcare research in over 65 countries including over 25 Low and Middle Income Countries (LMICs) across Asia, Central and Eastern Europe, Latin America, Middle East and North Africa, and Sub-Saharan Africa
While we have studied and conducted research for clients in a variety of health areas; our global health focus includes the following:
- Newborn and child health e.g., Pneumonia, Meningitis, Respiratory Syncytial Virus infections, Nutrition
- Reproductive Health and Family Planning
- Infectious Diseases including Ebola, Dengue, HIV / AIDS
- Non-communicable diseases (NCDs) including Diabetes, Cardiovascular health, Cancer
- Mental Health e.g., Depression and Schizophrenia
Our research has been published in peer-reviewed medical journals and presented at conferences. Find out more »
Lessons learned from our 20 years of experience
Through our work on 100+ projects conducting research with hard-to-reach populations and in countries with limited or disparate infrastructure, we have learned:
- the importance of collaboration throughout the research process
- the value of leveraging in-country contacts and networks to provide local expertise
Our approach is designed to deliver insights and data that meet the international best practices of conducting research.
Compliance, anti-bribery and corruption
It is very important to Research Partnership that our business is conducted in a transparent way to reflect our high ethical standards. We take compliance, anti-bribery and corruption extremely seriously and we have great confidence in the robustness of our compliance procedures.
Find out more »
Rachel is currently based in London, having previously lived and worked in the US and Asia. She has considerable experience managing large-scale multi-country research projects, with particular focus on conducting research in emerging markets, and willingness to pay / pricing research. Rachel's key healthcare areas of expertise include vaccines and infectious diseases.
- How buyer insights supported the development of an effective market strategy
The challengeOur client was developing a new product for HIV and needed to understand buyer willingness to pay in the emerging markets of South Africa, Kenya, and India. They needed to understand how new medicines are added to the guidelines and how they are evaluated and funded. They also needed to gain an understanding of stakeholders’ reactions to their product, the drivers and barriers to…read more »How the opportunity for a product treating a rare haematology disease in Emerging Markets was evaluated using a multi-stakeholder approach
Our client wanted to determine how to maximise the commercial opportunities for a product indicated for a rare disease in a range of emerging marketsread more »How mobile diaries were used to capture patient-generated insights in COPD
Research Partnership wanted to test the value and functionality of an app-based data collection tool which would give patients control of the market research interaction, and consequently deliver greater insights at key moments in the patient journey.read more »How a real-world methodology was used to understand the potential for a pre-launched product in type 2 diabetes
Our client was developing a new product for treating Type 2 diabetes, which they were preparing for launch. In an increasingly competitive diabetes market, with new brands and formulations frequently becoming available, our client needed to determine the unmet needs of current type 2 diabetes patients and identify where the greatest opportunity lay for their new product.read more »
- Our latest Global Health articlesTowards a culture of evaluation and evidence-based decision making in global health
Reflections on THET Conference 2016: Evidence, Effectiveness & Impactread more »In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
The UK’s Department for International Development (DfID) was established in 1997 with a mandate to tackle world poverty. Since its inception, it has played a major role in the global health landscape through bilateral programs, health partnerships, and the support of multilateral organisations, as well as influencing global health policy and international health research. Its future has come under increasing scrutiny following the UK referendum…read more »